Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial
Titel:
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial
Auteur:
Brown, Janet E Royle, Kara-Louise Gregory, Walter Ralph, Christy Maraveyas, Anthony Din, Omar Eisen, Timothy Nathan, Paul Powles, Tom Griffiths, Richard Jones, Robert Vasudev, Naveen Wheater, Matthew Hamid, Abdel Waddell, Tom McMenemin, Rhona Patel, Poulam Larkin, James Faust, Guy Martin, Adam Swain, Jayne Bestall, Janine McCabe, Christopher Meads, David Goh, Vicky Min Wah, Tze Brown, Julia Hewison, Jenny Selby, Peter Collinson, Fiona
Verschenen in:
Lancet oncology
Paginering:
Jaargang 24 () nr. 3 pagina's 213-227
Jaar:
2023
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license